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Congestion is at the heart of heart failure (Figure 1; 1, 2). Indeed, congestion and 
arrhythmias, which may not be unrelated, can be considered the two most important, 
therapeutic targets in patients with heart failure. Congestion is a key cause of exercise 
intolerance and symptoms and the most important cause of admissions for heart failure (3). 
Accordingly, managing congestion is a key task of the heart failure physician; it is also one of 
the most difficult. Guidelines on heart failure provide a plethora of advice on the use of 
neuro-endocrine antagonists but virtually no advice on how to use diuretics, which are 
probably the most used, abused and effective agents for managing congestion (4).   
 
In patients admitted with symptoms of worsening heart failure, evidence of congestion on 
clinical examination is often obvious, but not always (5). There can be considerable 
diagnostic uncertainty; there are many reasons for breathlessness and peripheral oedema 
other than heart failure. Moreover, peripheral congestion (oedema) may occur without 
cardiac congestion (an increase in atrial pressures) even in patients who have heart failure, 
especially during a diuresis, because of delays in repatriating fluid from tissues into the 
circulation. Aggressive diuresis in such patients may be deleterious, causing hypotension and 
renal dysfunction (6). Patients may also have cardiac congestion without peripheral oedema, 
because it takes time for raised pressures to translate into oedema, especially when lymphatic 
drainage is good or the patient is on bed rest and gravity has not taken its toll. Clinical 
inexperience, patient obesity and respiratory disease and the difficulty in eliciting clinical 
signs such as jugular venous distension add further confusion and complexity.  
 
A raised jugular venous pressure is probably the most reliable clinical sign of fluid overload 
and, when its assessment is performed by expert clinicians, it identifies patients with a worse 
outcome (7, 8). Recently, the increasing availability of portable, or hand-held, ultrasound 
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machines has stimulated interest in a more technologically sophisticated approach to the 
assessment of fluid status and congestion. The diameter of the inferior vena cava (IVC) can 
easily be measured with a modicum of training and offers a fairly reliable estimate of right 
atrial pressure. Measuring the IVC or the internal jugular vein diameter, with their responses 
to respiratory manoeuvres, allows an even more precise, reproducible and objective measure 
of the severity of congestion (9, 10). Thus, imaging the IVC is a quick and convenient 
method for routinely assessing cardiac congestion at the bedside in patients with suspected 
heart failure that not only helps confirm the diagnosis but might also guide diuretic therapy 
and the timing of discharge. It can also provide prognostic information complementary to that 
obtained clinically or by measuring plasma concentrations of natriuretic peptides and 
independent from other measures of cardiac function such as left ventricular ejection fraction; 
congestion is similarly bad news whether the patients has HFrEF or HFpEF (11,12).  
Algorithms for the assessment of congestion have been proposed, but do not yet include 
venous ultrasound. Some variables used in these models, such as the severity of dyspnoea or 
fatigue, are subjective and open to assessment bias by the patient and clinician, and others, 
such as the clinical assessment of JVP, also require considerable clinical skill. Using such 
criteria, up to 40% of patients admitted with worsening heart failure will still have at least 
moderate congestion at discharge (13). Failure to control congestion places the patient at high 
risk of recurrent hospitalization and death (1, 14). 
 
In the current issue of this journal, Dr. Josa-Laorden and colleagues provide interesting 
insight into these issues. They prospectively followed 85 patients for six months after an 
admission for worsening heart failure; two-thirds of patients had an LVEF >50%. IVC 
diameter was measured within 24h of admission using a portable hand-held device. Most 
patients had a dilated (>2.0cm) IVC (55%) or attenuation of the normal inspiratory IVC 
Page 4 of 8 
 
collapse (70%); of those with a dilated IVC, only 5 (11%) had a normal (>50%) inspiratory 
response. Patients with a dilated IVC were more likely to have a distended JVP and 
hepatomegaly on physical examination, and higher plasma concentrations of biomarkers 
reflecting volume overload, such as NTproBNP and CA125. Patients who had a dilated IVC 
that failed to collapse appropriately during inspiration had the worst outcome. A few patients 
had an apparently dilated IVC but with appropriate collapse on inspiration and appeared to 
have less advanced heart failure. These might simply have been larger patients with a 
naturally larger IVC; alternatively, restoration of the inspiratory collapse may precede 
reduction in IVC diameter in patients responding to diuretic therapy or patients who are less 
sick may be able to generate a greater inspiratory pressure. Conversely, patients whose IVC 
was not dilated but failed to collapse appropriately appeared sicker; perhaps IVC dilatation 
depends on the chronicity as well as severity of congestion. As highlighted by the authors, the 
studied sample-size was small, and some mismeasurement and misclassification is inevitable, 
especially when the result is binary – a 49% or 51% IVC collapse are unlikely to carry 
different biological meaning. Using two or more threshold criteria (eg:- >60%; 30-60% and 
<30% collapse) to classify people into high, low and intermediate groups would likely 
improve the clinical and prognostic utility of the measurement. Other factors might have 
influenced these results: we do not know the time interval between the onset of symptoms 
that prompted the hospital admission and the ultrasound assessment or the total amount of 
diuretics administered. It would have been useful to have had measurements before and after 
treatment. The acute effects of diuretic treatment may have a more marked effect on IVC 
collapsibility than on its diameter (15): whether this reflects an acute haemodynamic response 
to diuretics, or improved inspiratory performance, or both is not clear. Finally, it is unknown 
in how many patients a correct IVC visualisation was possible. 
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Importantly, discrepancies might exist between clinical and echocardiographic assessment of 
fluid overload. Of those with a non-dilated IVC, 42% were considered to have a distended 
JVP on clinical examination, whilst 35% of those with a dilated IVC were reported not to 
have a distended JVP. This highlights the possible subjectivity of the clinical examination, 
some measurement error during imaging and the need for more objective and standardised 
methods for assessing congestion. However, as noted above, there may be other factors that 
affect the relationship between right atrial pressure and IVC diameter, such as disease 
chronicity and the acute response to therapy.  
 
In summary, ultrasound assessment of the IVC in patients admitted with suspected heart 
failure appears helpful in assessing congestion and stratifying risk; whether it adds useful 
information to the clinical examination, which may depend on the clinician’s expertise, and 
whether it can be used to guide therapy or the timing of discharge awaits further 
investigation. Alternative invasive and non-invasive devices for measuring atrial pressure and 
congestion should also be considered for the acute and long-term management of fluid 
balance. If congestion can be mastered the war on heart failure is at least half-won (1, 14).  
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Legend to figure 1. Schematic diagram showing factors important to the development of 
moderate, or more severe congestion in patients with heart failure, reflected by a dilated but 
still collapsible inferior vena cava (IVC; a), or a dilated and stiff IVC at echocardiography 
(b), respectively. Cardiac dysfunction leads to a rise in atrial pressures and/or a fall in 
systemic arterial pressure. The fall in net renal perfusion pressure triggers salt and water 
retention causing an expansion in circulatory volume and a further rise in atrial pressure. This 
may lead to peripheral (including renal parenchymal) oedema (6). Rising venous pressure and 
the inability of plasma volume expansion to restore systemic arterial pressure triggers further 
salt and water retention. The increase in the diameter of the IVC may reflect the chronicity of 
the elevation in RA pressure; the failure of the IVC to collapse on inspiration could reflect an 
acute on chronic component. Response to diuretics will likely restore the inspiratory response 
before an effect is observed on IVC diameter. 
 
 
 
 
 

